← Eichor
Study identifier: NCT07352514 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

Condition: Chemotherapy-induced Peripheral Neuropathy (CIPN) · Neuropathic Pain  ·  Sponsor: University of Palermo

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to find out if taking specific dietary supplements (PEA and Scutellaria) along with therapeutic exercise can help reduce nerve pain and damage caused by chemotherapy. Many cancer patients experience nerve-related side effects from chemotherapy, which can significantly impact their quality of life. The study will observe patients who use these supplements and exercises to see if they can effectively manage and improve their nerve health and reduce pain.

This description comes directly from the study's public registry record.

Talk to the study team

Giulia Letizia Mauro  ·  +39 0916554160 +39 09165541  ·  giulia.letiziamauro@unipa.it

Always discuss trial participation with your own doctor first.

Locations (1)

A.O.U.P. P. Giaccone, Palermo, Italia 90127Palermo, Italia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07352514